tradingkey.logo

Elevance Health beats Q3 profit estimates, reaffirms annual profit guidance

ReutersOct 21, 2025 10:10 AM


Overview

  • Elevance Health Q3 2025 operating revenue rose 12% yr/yr to $50.1 bln

  • Adjusted EPS for Q3 2025 beats analyst expectations

  • Benefit expense ratio increased to 91.3%


Outlook

  • Elevance Health reaffirms FY 2025 adjusted EPS guidance of approximately $30.00

  • Company focuses on advancing affordability and improving member experience

  • Elevance Health plans for sustainable growth and value creation in 2026


Result Drivers

  • PREMIUM YIELDS - Higher premium yields in Health Benefits segment contributed to revenue growth

  • MEDICARE ADVANTAGE GROWTH - Growth in Medicare Advantage membership supported revenue increase

  • CAREYON ACQUISITIONS - Acquisitions in home health and pharmacy services boosted Carelon revenue


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Operating Revenue

$50.1 bln

Q3 Adjusted EPS

Beat

$6.03

$4.93 (20 Analysts)

Q3 EPS

$5.32

Q3 Benefit Expense Ratio

91.30%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 11 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the managed healthcare peer group is "buy"

  • Wall Street's median 12-month price target for Elevance Health Inc is $382.50, about 7.4% above its October 20 closing price of $354.07

  • The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nBw8JbVSTa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI